MINNEAPOLIS, Feb. 4, 2021 /PRNewswire/ — Vireo Health International Inc., (“Vireo” or the “Company”) (CNSX: VREO,OTCQX: VREOF), the leading physician-founded, science-focused multi-state cannabis company, today announced the filing of a registration statement on Form S-8 with the United States Securities and Exchange Commission (“SEC”).
The Form S-8 registers previously issued securities under the Company’s equity incentive plans with the SEC, as well as shares which may be issued under similar plans in the future with the approval of the Company’s Board of Directors. These securities were previously only registered in Canada.
After becoming a full SEC reporting company earlier this year, today’s filing represents another administrative step in our planned transition to listing on a U.S. exchange sometime in the future.
Chief Executive Officer, Dr. Kyle Kingsley, M.D.
We plan to maintain our public listing in Canada, but we expect to continue experiencing significant increases in demand for our shares in the United States and we believe it’s critical that all shares be registered with the SEC as soon as practicably possible.
About Vireo Health International, Inc.
Vireo Health International, Inc. is a physician-led cannabis company focused on bringing the best of technology, science, and engineering to the cannabis industry. Vireo manufactures proprietary, branded cannabis products in environmentally-friendly, state-of-the-art greenhouses and other facilities and distributes its products through its growing network of Green Goods™ retail locations and third-party dispensaries. Vireo’s team of more than 400 employees, led by scientists, engineers, and cultivation experts, is focused on efficiency and the creation of best-in-class products, while driving scientific innovation within the cannabis industry and developing meaningful intellectual property. Today, Vireo is licensed to grow and/or process cannabis in seven markets. The Company is operational in five of those markets – including the core markets of Arizona, Maryland, Minnesota, New Mexico, and New York. The Company holds 29 total retail dispensary licenses, of which 16 are currently open for business. For more information about Vireo Health, please visit www.vireohealth.com.
